HLA-haploidentical anti-CD19 CAR-T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HLA-haploidentical anti-CD19 CAR-T cells, covering 2026-01-23 to 2026-01-23. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation [Phase 1]